SCHEMBL173281

SCHEMBL173281

O=C(CN1CCCC1c1cccnc1)NO

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.63
▸ KDM4E B2RXH2 3/20 0.63
▸ TDP1 Q9NUW8 3/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ HPGD P15428 1/20 0.63
▸ CHRNA7 P36544 3/20 0.53
▸ CHRNB2 P17787 3/20 0.53
▸ CHRNA4 P43681 3/20 0.53
▸ CHRNB4 P30926 2/20 0.53
▸ CHRNA3 P32297 2/20 0.53
▸ CHRNA2 Q15822 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HTR3E A5X5Y0 1/20 0.53
▸ PSIP1 O75475 1/20 0.53
▸ TRPA1 O75762 1/20 0.53
▸ HTR3B O95264 1/20 0.53
▸ CHRNA1 P02708 1/20 0.53
▸ CHRNG P07510 1/20 0.53
▸ MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3262479 0.85 ALDH1A1 (0.71) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL524920 0.84 ALDH1A1 (0.66) ALDH1A1KDM4ETDP1KMT2AMEN1
Lithium Ion SCHEMBL2682486 0.83 ALDH1A1 (0.65) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL2683364 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL29980501 0.81 ALDH1A1 (0.72) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL157171 0.78 ALDH1A1 (0.66) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL3369061 0.78 ALDH1A1 (0.61) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL20590950 0.78 ALDH1A1 (0.62) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL28497766 0.78 ALDH1A1 (0.66) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL854070 0.78 ALDH1A1 (0.61) ALDH1A1KDM4ETDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611788-B1 NICOTINE COMPOUNDS AND ANALOGS THEREOF, SYNTHETIC METHODS OF MAKING COMPOUNDS, AND METHODS OF USE UNIV FLORIDA (US) 2017-04-12 — — EP disclosed
US-9440948-B2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-09-13 — — US disclosed
EP-2611788-A2 NICOTINE COMPOUNDS AND ANALOGS THEREOF, SYNTHETIC METHODS OF MAKING COMPOUNDS, AND METHODS OF USE University of Florida Research Foundation, Incorporated (US) 2013-07-10 — — EP disclosed
US-20130157995-A1 NICOTINE COMPOUNDS AND ANALOGS THEREOF, SYNTHETIC METHODS OF MAKING COMPOUNDS, AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-06-20 — — US disclosed
WO-2012031220-A2 NICOTINE COMPOUNDS AND ANALOGS THEREOF, SYNTHETIC METHODS OF MAKING COMPOUNDS, AND METHODS OF USE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2012-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130157995-A1 NICOTINE COMPOUNDS AND ANALOGS THEREOF, SYNTHETIC METHODS OF MAKING COMPOUNDS, AND METHODS OF USE CHRNG, CHRNB1, CHRNB2 ALDH1A1 1312/4885KDM4E 391/4885TDP1 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback